EUVIMEDEUVIMED entdecken
Crossref

Incidence of anti‐neutrophil cytoplasmic antibody‐associated renal vasculitis: a retrospective study in rural and regional Victoria, Australia

Georgina Oakman iD, Cindy-Anne Bach, Cindy Ong

Internal Medicine Journal · 2024

DOI: 10.1111/imj.16127 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Internal Medicine Journal, 2024. Verfasst von Georgina Oakman und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Renal Medicine, Bendigo Health, Victoria, Bendigo, Australia. Hauptthemen laut MEDLINE: Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis, Microscopic Polyangiitis, Granulomatosis with Polyangiitis. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 25 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The epidemiology of anti‐neutrophil cytoplasmic antibody (ANCA)‐associated vasculitis (AAV) varies worldwide. Previous Australian studies described a higher incidence of AAV in rural areas; however, this has not yet been investigated in Victoria.

Aims

To calculate the incidence of AAV in rural and regional Victoria and characterise the demographics and clinical outcomes of this cohort.

Methods

We performed a retrospective review of patients with newly diagnosed AAV confirmed on renal biopsy at Bendigo Health between 2013 and 2021. Cases were classified according to the 2022 American College of Rheumatology/European Alliance of Associations for Rheumatology criteria. Local disease incidence was calculated using Estimated Resident Population data for our catchment, the Loddon Mallee region.

Results

Twenty‐eight cases of new AAV were identified; 17 were classified as microscopic polyangiitis (MPA) and the remainder as granulomatosis with polyangiitis (GPA). The median age at diagnosis was 68 years (interquartile range (IQR): 59–77). The incidence per million person‐years was 9.3 for AAV overall (95% CI: 6.2–13.5), 5.7 for MPA (95% CI: 3.3–9.1) and 3.7 for GPA (95% CI: 1.8–6.6). With a median follow‐up time of 3.3 years (IQR: 1.9–5.6), one‐quarter of patients relapsed ( n = 7, 25%), and six required ongoing renal‐replacement therapy (21%).

Conclusions

The calculated incidence of AAV in rural and regional Victoria is not higher than the reported incidence in most urban Australian cohorts. This study may underestimate the true local disease incidence as only patients with renal vasculitis were included.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Anti-Neutrophil Cytoplasmic Antibody-Associated VasculitisMicroscopic PolyangiitisGranulomatosis with PolyangiitisHumansAgedRetrospective StudiesAntibodies, Antineutrophil CytoplasmicVictoriaIncidence

Stichwörter der Autor:innen

Australiaanti-neutrophil cytoplasmic antibody-associated vasculitisgranulomatosis with polyangiitisincidencemicroscopic polyangiitis

Substanzen

Antibodies, Antineutrophil Cytoplasmic

Autor:innen und Institutionen

  • Department of Renal Medicine, Bendigo Health, Victoria, Bendigo, Australia.
  • Department of Medicine, Austin Health, Victoria, Heidelberg, Australia.

ORCID-Profile: Georgina Oakman

Zitieren

APA

Oakman, G., Bach, C. A., & Ong, C. (2024). Incidence of anti‐neutrophil cytoplasmic antibody‐associated renal vasculitis: a retrospective study in rural and regional Victoria, Australia. Internal Medicine Journal. https://doi.org/10.1111/imj.16127

Vancouver

Oakman G, Bach CA, Ong C. Incidence of anti‐neutrophil cytoplasmic antibody‐associated renal vasculitis: a retrospective study in rural and regional Victoria, Australia. Internal Medicine Journal. 2024. doi:10.1111/imj.16127

BibTeX
@article{Oakman2024,
  author = {Oakman, Georgina and Bach, Cindy-Anne and Ong, Cindy},
  title = {Incidence of anti‐neutrophil cytoplasmic antibody‐associated renal vasculitis: a retrospective study in rural and regional Victoria, Australia},
  journal = {Internal Medicine Journal},
  year = {2024},
  doi = {10.1111/imj.16127}
}
Kostenlos starten →